About
Rehaler was a Danish biomedical and medtech company that focused on developing a drug-free device for treating acute migraine attacks, particularly migraine with aura. The company’s innovative technology aimed to modulate carbon dioxide and oxygen levels in the central nervous system to provide therapeutic effects. Their primary product was designed as an alternative to traditional pharmaceutical treatments for migraines. Headquartered in Copenhagen, Denmark, Rehaler operated in the health services and manufacturing sectors with a business-to-business model. The company attracted approximately $2.52 million in investment from various investors during its operation. Rehaler targeted healthcare providers, clinics, and distributors interested in offering a non-pharmaceutical option for migraine treatment.
Technologies
Company Information
-
Employees 5
-
Founded 2020
Location
Copenhagen, Capital Region of Denmark, Denmark
